A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemia

Clinical Lymphoma, Myeloma and Leukemia

Volumn 14, Issue 5, 2014, Pages 401-410

  Quintás Cardama, Alfonso ^a   Daver, Naval ^a   Kim, Hawk ^b   Dinardo, Courtney ^a   Jabbour, Elias ^a   Kadia, Tapan ^a   Borthakur, Gautam ^a   Pierce, Sherry ^a   Shan, Jianqin ^a   Cardenas Turanzas, Marylou ^a   Cortes, Jorge ^a   Ravandi, Farhad ^a   Wierda, William ^a   Estrov, Zeev ^a   Faderl, Stefan ^a   Wei, Yue ^a   Kantarjian, Hagop ^a   Garcia Manero, Guillermo ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Prognostic model; Secondary; Survival; Therapy related MDS; Transformation

Indexed keywords

ALKYLATING AGENT; BETA 2 MICROGLOBULIN; GYRASE INHIBITOR; HEMOGLOBIN; SERUM ALBUMIN; ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CHROMOSOME 20Q; CHROMOSOME 5Q; CHROMOSOME DELETION Y; CYTOGENETICS; DIPLOIDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HEPATOMEGALY; HIGH RISK POPULATION; HUMAN; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PATIENT HISTORY OF CHEMOTHERAPY; PATIENT HISTORY OF RADIOTHERAPY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SEX DIFFERENCE; SURVIVAL PREDICTION; THROMBOCYTE COUNT; ADVERSE EFFECTS; BIOLOGICAL MODEL; BLOOD TRANSFUSION; CHEMICALLY INDUCED; DISEASE COURSE; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; KAPLAN MEIER METHOD; LEUKEMIA, MYELOID, ACUTE; LEUKEMIA, RADIATION-INDUCED; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROMES; NEOPLASMS, SECOND PRIMARY; PATHOLOGY; RADIOTHERAPY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BLOOD TRANSFUSION; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINS; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKEMIA, MYELOID, ACUTE; LEUKEMIA, RADIATION-INDUCED; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROMES; NEOPLASMS, SECOND PRIMARY; PLATELET COUNT; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY; RISK FACTORS; YOUNG ADULT;

EID: 84908691827     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2014.03.001     Document Type: Article

References (44)

1. J.M. Bennett, D. Catovsky, and M.T. Daniel Proposals for the classification of the myelodysplastic syndromes Br J Haematol 51 1982 189 199
2. S.D. Nimer Myelodysplastic syndromes Blood 111 2008 4841 4851
3. J.D. Rowley, H.M. Golomb, and J.W. Vardiman Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease Blood 58 1981 759 767
4. M.M. Le Beau, K.S. Albain, and R.A. Larson Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7 J Clin Oncol 4 1986 325 345
5. M.J. Thirman, and R.A. Larson Therapy-related myeloid leukemia Hematol Oncol Clin North Am 10 1996 293 320
6. J. Pedersen-Bjergaard, P. Philip, and B.T. Mortensen Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. Clinical and cytogenetic characteristics and results of in vitro culture of bone marrow and HLA typing Blood 57 1981 712 723
7. S. Swerdlow, E. Campos, and N. Harris Therapy-related myeloid neoplams S. Swerdlow, E. Campos, N. Harris, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008 International Agency for Research on Cancer Lyon 127
8. S. Bhatia, and C. Sklar Second cancers in survivors of childhood cancer Nat Rev Cancer 2 2002 124 132
9. S. Bhatia, L.L. Robison, and O. Oberlin Breast cancer and other second neoplasms after childhood Hodgkin's disease N Engl J Med 334 1996 745 751
10. S. Bhatia, M.D. Krailo, and Z. Chen Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: a report from the Children's Oncology Group Blood 109 2007 46 51
11. R.E. Curtis, P.A. Rowlings, and H.J. Deeg Solid cancers after bone marrow transplantation N Engl J Med 336 1997 897 904
12. S.M. Smith, M.M. Le Beau, and D. Huo Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series Blood 102 2003 43 52
13. J. Pedersen-Bjergaard, and P. Philip Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II Blood 78 1991 1147 1148
14. J.E. Karp, and C.B. Sarkodee-Adoo Therapy-related acute leukemia Clin Lab Med 20 2000 71 81 ix
15. H.J. Olney, and M.M. Le Beau The cytogenetics of myelodysplastic syndromes Best Pract Res Clin Haematol 14 2001 479 495
16. M. Cazzola, and L. Malcovati Myelodysplastic syndromes-coping with ineffective hematopoiesis N Engl J Med 352 2005 536 538
17. N.L. Harris, E.S. Jaffe, and J. Diebold The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997 Ann Oncol 10 1999 1419 1432
18. P. Greenberg, C. Cox, and M.M. LeBeau International scoring system for evaluating prognosis in myelodysplastic syndromes Blood 89 1997 2079 2088
19. L. Malcovati, U. Germing, and A. Kuendgen Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes J Clin Oncol 25 2007 3503 3510
20. G. Garcia-Manero, J. Shan, and S. Faderl A prognostic score for patients with lower risk myelodysplastic syndrome Leukemia 22 2008 538 543
21. H. Kantarjian, S. O'Brien, and F. Ravandi Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System Cancer 113 2008 1351 1361
22. M. Ando, M. Narabayashi, and T. Watanabe Therapy-related leukemia and myelodysplastic syndrome in breast cancer patients treated with cyclophosphamide or anthracyclines Jpn J Clin Oncol 29 1999 28 32
23. C. Arana-Yi, A.W. Block, and S.N. Sait Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: possible role of cytarabine Leuk Res 32 2008 1043 1048
24. W.Y. Au, C.C. Lam, and E.S. Ma Therapy-related myelodysplastic syndrome after eradication of acute promyelocytic leukemia: cytogenetic and molecular features Hum Pathol 32 2001 126 129
25. S.J. Bowcock, S.M. Rassam, and Z. Lim High incidence of therapy-related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disorders Br J Haematol 134 2006 242 243
26. N. Fukuda, K. Shinohara, and I. Ota Therapy-related myelodysplastic syndrome in a case of cutaneous adult T-cell lymphoma Int J Hematol 75 2002 67 71
27. G. Garcia-Manero, H.M. Kantarjian, and S. Kornblau Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL) Leukemia 16 2002 1888
28. A. Hayani, D.H. Mahoney Jr., and L.D. Taylor Therapy-related myelodysplastic syndrome in children with medulloblastoma following MOPP chemotherapy J Neurooncol 14 1992 57 62
29. G. Nichols, K. de Castro, and L.X. Wei Therapy-related myelodysplastic syndrome after autologous stem cell transplantation for breast cancer Leukemia 16 2002 1673 1679
30. C. Papageorgio, K. Seiter, and E.J. Feldman Therapy-related myelodysplastic syndrome in adults with neurofibromatosis Leuk Lymphoma 32 1999 605 608
31. L.E. Robertson, E. Estey, and H. Kantarjian Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia Leukemia 8 1994 2047 2051
32. G.J. Roboz, J.M. Bennett, and M. Coleman Therapy-related myelodysplastic syndrome and acute myeloid leukemia following initial treatment with chemotherapy plus radioimmunotherapy for indolent non-Hodgkin lymphoma Leuk Res 31 2007 1141 1144
33. L.R. Rogers, N. Janakiraman, and C. Kasten-Sportes Therapy-related myelodysplastic syndrome (t-MDS) in a patient with anaplastic astrocytoma: successful treatment with allogeneic bone marrow transplant J Neurooncol 53 2001 55 59
34. C. Hosing, M. Munsell, and S. Yazji Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma Ann Oncol 13 2002 450 459
35. R.D. Legare, J.G. Gribben, and M. Maragh Prediction of therapy-related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphoma Am J Hematol 56 1997 45 51
36. H. Sill, W. Olipitz, and M.G. Schimek Therapy-related myelodysplastic syndrome and acute myeloid leukemia after autologous bone marrow transplantation: dosis facit venenum? J Clin Oncol 23 2005 8120 8121 author reply 8121-2
37. D. Verma, S. O'Brien, and D. Thomas Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimens Cancer 115 2009 101 106
38. P. Fenaux, G.J. Mufti, and E. Hellstrom-Lindberg Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study Lancet Oncol 10 2009 223 232
39. A. Quintas-Cardama, F.P. Santos, and G. Garcia-Manero Therapy with azanucleosides for myelodysplastic syndromes Nat Rev Clin Oncol 7 2010 433 444
40. Z.N. Singh, D. Huo, and J. Anastasi Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant Am J Clin Pathol 127 2007 197 205
41. H.M. Kantarjian, M.J. Keating, and R.S. Walters Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features J Clin Oncol 4 1986 1748 1757
42. K. Takeyama, M. Seto, and N. Uike Therapy-related leukemia and myelodysplastic syndrome: a large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors Int J Hematol 71 2000 144 152
43. M. Lessard, C. Helias, and S. Struski Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ? Cancer Genet Cytogenet 176 2007 1 21
44. A. Iurlo, C. Mecucci, and A. Van Orshoven Cytogenetic and clinical investigations in 76 cases with therapy-related leukemia and myelodysplastic syndrome Cancer Genet Cytogenet 43 1989 227 241